IRIS
MAPELLI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.954
AS - Asia 2.253
NA - Nord America 2.228
SA - Sud America 507
AF - Africa 49
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 4
Totale 8.015
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.125
RU - Federazione Russa 1.622
SG - Singapore 793
CN - Cina 703
BR - Brasile 401
IT - Italia 359
HK - Hong Kong 271
SE - Svezia 265
VN - Vietnam 235
DE - Germania 155
FR - Francia 123
ES - Italia 104
FI - Finlandia 99
GB - Regno Unito 83
IN - India 69
CA - Canada 59
AR - Argentina 41
PL - Polonia 35
MX - Messico 32
BD - Bangladesh 27
NL - Olanda 25
IE - Irlanda 23
TR - Turchia 23
ID - Indonesia 21
JP - Giappone 20
ZA - Sudafrica 20
AT - Austria 19
AU - Australia 19
EC - Ecuador 18
IQ - Iraq 15
CO - Colombia 12
CL - Cile 11
UZ - Uzbekistan 10
PK - Pakistan 9
PY - Paraguay 9
LT - Lituania 8
MA - Marocco 8
MY - Malesia 7
PE - Perù 7
PT - Portogallo 7
SA - Arabia Saudita 7
UA - Ucraina 7
JO - Giordania 6
KE - Kenya 6
IL - Israele 5
NP - Nepal 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BE - Belgio 4
IR - Iran 4
TN - Tunisia 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
RO - Romania 3
TW - Taiwan 3
UY - Uruguay 3
VE - Venezuela 3
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
EU - Europa 2
KZ - Kazakistan 2
MD - Moldavia 2
PA - Panama 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BW - Botswana 1
BZ - Belize 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KR - Corea 1
LV - Lettonia 1
MR - Mauritania 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
Totale 8.015
Salva come PNG Salva come JPEG
Città #
Dallas 580
Singapore 401
Moscow 329
Ashburn 305
Hong Kong 268
San Jose 200
Milan 167
Shanghai 144
Beijing 132
New York 121
Hefei 92
Valencia 86
Ho Chi Minh City 85
Lauterbourg 79
Munich 75
Lawrence 63
Princeton 63
Hanoi 54
Los Angeles 54
Turku 50
Boardman 45
Helsinki 41
Orem 41
São Paulo 36
Santa Clara 29
Chennai 24
Montreal 24
Rome 24
Warsaw 24
Dublin 23
Brooklyn 20
Frankfurt am Main 20
London 20
Manchester 16
Atlanta 15
Chicago 15
Poplar 15
Stockholm 15
Tokyo 15
Seattle 14
The Dalles 14
Toronto 14
Ankara 13
Columbus 13
Amsterdam 12
Denver 12
Johannesburg 12
Mumbai 12
Da Nang 11
Haiphong 11
Houston 11
Nuremberg 11
Phoenix 11
Washington 11
Guangzhou 10
Mexico City 10
New Delhi 10
Rio de Janeiro 10
Bexley 9
Falkenstein 9
Naples 9
San Francisco 9
Tashkent 9
Council Bluffs 8
Fortaleza 8
Philadelphia 8
West Jordan 8
Belo Horizonte 7
Buffalo 7
Dhaka 7
Lappeenranta 7
Quito 7
Santiago 7
Secaucus 7
Vienna 7
Barnet 6
Boston 6
Canberra 6
Curitiba 6
Guayaquil 6
Hangzhou 6
Lima 6
Shenzhen 6
Adelaide 5
Amman 5
Baghdad 5
Brasília 5
Can Tho 5
Guarulhos 5
Hamilton 5
Itaquaquecetuba 5
Kuala Lumpur 5
Lublin 5
Manaus 5
Paris 5
Pessano Con Bornago 5
Querétaro 5
Sydney 5
São João da Madeira 5
Aracaju 4
Totale 4.297
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/MRI in endometrial cancer: systematic review and meta-analysis 179
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 178
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 172
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease 169
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 161
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 157
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 155
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 154
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 151
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers 139
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 138
External validation of a convolutional neural network for the automatic segmentation of intraprostatic tumor lesions on 68Ga-PSMA PET images 126
null 126
18F-FAZA PET/CT in the Preoperative Evaluation of NSCLC: Comparison with 18F-FDG and Immunohistochemistry 126
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 125
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 125
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 121
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 120
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort 120
18F-FAZA PET imaging in tumor hypoxia: A focus on high-grade glioma 118
18F-FAZA PET/CT Hypoxia Imaging of High-Grade Glioma Before and After Radiotherapy 117
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study 116
11C-Choline PET/CT based Helical Tomotherapy as Treatment Approach for Bone Metastases in Recurrent Prostate Cancer Patients 115
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 114
Hypoxia pathway: 18F-FAZA 114
11C-or18F-Choline PET/CT for imaging evaluation of biochemical recurrence of prostate cancer 113
[¹⁸F]fluorodeoxyglucose positron emission tomography/computed tomography and trophoblastic disease: the gynecologist perspective 112
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 111
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 110
Clinical implication of multimodality imaging of aortic root intramural hematoma 109
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 108
PSMA PET in brain metastases: navigating diagnostic challenges– a thorough exploration 105
State of the art of radiomic analysis in the clinical management of prostate cancer: A systematic review 104
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 101
Systematic Review and Metanalysis on the Role of Prostate-Specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging for Intraprostatic Tumour Assessment 101
[Multi-modality imaging: mycotic abscess of a pericardial patch]. FT Imaging multimodale: ascesso micotico su patch di pericardio 100
Association of IgG4-related disease and systemic rheumatic disorders 99
Radiomics and artificial intelligence 97
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness 96
Hypoxia PET imaging beyond 18F-FMISO in patients with high-grade glioma: 18F-FAZA and other hypoxia radiotracers 96
Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Non-Functioning Pancreatic Neuroendocrine Tumors 93
PSMA and Choline PET for the Assessment of Response to Therapy and Survival Outcomes in Prostate Cancer Patients: A Systematic Review from the Literature 91
Synergic role of preoperative 18F-fluorodeoxyglucose PET and MRI parameters in predicting histopathological features of endometrial cancer 85
The Challenge of External Generalisability: Insights from the Bicentric Validation of a [68Ga]Ga-PSMA-11 PET Based Radiomics Signature for Primary Prostate Cancer Characterisation Using Histopathology as Reference 84
Choline PET/CT features to predict survival outcome in high risk prostate cancer restaging: a preliminary machine-learning radiomics study 84
Dual tracer 68Ga-DOTATOC and 18F-FDG PET/computed tomography radiomics in pancreatic neuroendocrine neoplasms: An endearing tool for preoperative risk assessment 84
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 78
Concomitant Lung Cancer and Gastrointestinal Stromal Tumor: First Report of Hypoxia Imaging With 18F-FAZA PET/CT 76
18F-FDG PET/CT for Early Postradiotherapy Assessment in Solitary Bone Plasmacytomas 74
Imaging in evaluation of response to neo-adjuvant treatment 74
Hypoxia and Amino Acid Imaging of High-Grade Glioma18F-FAZA PET/CT and 11C-Methionine PET/MRI 72
The potential role of osteoporosis in unspecific [18F]PSMA-1007 bone uptake 70
Radiation treatment of lymph node recurrence from prostate cancer: Is 11C-choline PET/CT predictive of survival outcomes? 67
The role of 18F-FAZA PET/CT in detecting lymph node metastases in renal cell carcinoma patients: a prospective pilot trial 67
Dual tracer 68ga-dotatoc and 18f-fdg pet improve preoperative evaluation of aggressiveness in resectable pancreatic neuroendocrine neoplasms 67
Nuclear medicine in prostate cancer management 66
Combined 68Ga-DOTA-peptides and 18F-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) 64
PET/MRI and prostate cancer 63
Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer 63
Early variation of 18-fluorine-labelled fluorodeoxyglucose PET-derived parameters after chemoradiotherapy as predictors of survival in locally advanced pancreatic carcinoma patients 61
Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis 58
FDG PET-derived parameters as prognostic tool in progressive malignant pleural mesothelioma treated patients 57
The role of positron emission tomography/computed tomography (Pet/ct) for staging and disease response assessment in localized and locally advanced pancreatic cancer 55
Pancreatic metastases from primary ileal NET only detected by 68Ga-DOTATOC PET/CT 54
PET imaging for lymph node dissection in prostate cancer 53
Evaluation of prostate cancer with11C-Choline PET/CT for treatment planning, response assessment, and prognosis 52
Hypoxia18F-FAZA PET/CT imaging in lung cancer and high-grade glioma: open issues in clinical application 52
PET/MRI in Neuroendocrine Tumours: Blessings and Curses 52
The relationship between local recurrences and distant metastases in prostate cancer: can11C-choline PET/CT contribute to understand the link? 52
Incidental Finding of Parathyroid Adenoma With C-11-Choline PET/CT 51
PET/MRI 50
Role of 18F-FDG PET in the management of gestational trophoblastic neoplasia 49
Lymph nodal metastases: diagnosis and treatment 49
POSITRON EMISSION TOMOGRAPHY/MAGNETIC RESONANCE IMAGING 48
Sarcoidosis mimicking metastatic gynaecological malignancies: A diagnostic and therapeutic challenge? 48
Clinical PET imaging of tumour hypoxia in lung cancer 48
DETECTION OF BONE METASTASES AND EVALUATION OF THERAPY RESPONSE IN PROSTATE CANCER PATIENTS BY RADIOLABELLED CHOLINE PET/CT 48
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL 46
PET/MRI in gynecological tumors 45
Detection of bone metastases and evaluation of therapy response in prostate cancer patients by radiolabelled choline PET/CT 45
Initial prostate cancer diagnosis and disease staging - The role of choline-PET-CT 45
FDG-PET/CT predicts outcome in oropharingeal carcinoma patients undergoing intensity modulated radiation therapy with dose escalation to FDG-avid tumour volumes 45
Imaging biomarkers in prostate cancer: role of PET/CT and MRI 44
Predictive value of pre-therapy 18F-FDG PET/CT for the outcome of 18F-FDG PET-guided radiotherapy in patients with head and neck cancer 42
Imaging biomarkers in ovarian cancer: the role of ¹⁸F-FDG PET/CT 42
Optical imaging in lung cancer—follow the light, towards molecular imaging–guided precision surgery 42
Spinal cord involvement secondary to non-Hodgkin's lymphoma identified by F-18-FDG PET/CT 41
Prostate cancer recurrence: can PSA guide imaging? 41
Erdheim-Chester Disease Imaging-Guided Therapeutic Approach 40
Reply to the letter "Choline PET/CT compared with bone scintigraphy in the detection of bone metastases in prostate cancer patients" 40
PET guidance in prostate cancer radiotherapy: Quantitative imaging to predict response and guide treatment 39
[18F]FDG PET/MRI in Endometrial Cancer: Prospective Evaluation of Preoperative Staging, Molecular Characterization and Prognostic Assessment 38
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on F-18-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 38
TECNICHE, METODOLOGIE, APPLICAZIONI DIAGNOSTICA PER IMMAGINI 38
High-grade endometrial cancer: value of [F-18]FDG PET/CT in preoperative staging 36
Diagnostic Accuracy of Fully Hybrid PET/MRI with [68 Ga]Ga-PSMA-11 and [68 Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard 36
null 23
Data-Driven Motion Correction of 11C-Methionine PET Images on a Cohort of Pediatric Patients With Brain Tumor in a PET/MRI Study 23
The relationship between gleason score and 11c-choline pet/ct positive detection rate in prostate cancer patients with biochemical failure after radical prostatectomy: biological and methodological factors 22
Per-Lesion Assessment of Individual MRI Sequences and 68Ga-DOTATATE PET in Neuroendocrine Liver Metastases 15
Totale 8.223
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.967
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.967
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022106 0 6 0 31 11 5 9 11 14 11 2 6
2022/2023526 145 95 42 30 20 49 39 52 9 22 3 20
2023/2024604 44 27 109 64 40 91 22 56 9 20 33 89
2024/20251.475 144 33 43 41 88 113 264 140 173 145 122 169
2025/20265.453 392 378 725 710 447 172 447 406 1.496 280 0 0
Totale 8.234